Page last updated: 2024-11-07

fluprednisolone and Uveitis, Intermediate

fluprednisolone has been researched along with Uveitis, Intermediate in 2 studies

Fluprednisolone: A synthetic glucocorticoid with anti-inflammatory properties.

Uveitis, Intermediate: Inflammation of the pars plana, ciliary body, and adjacent structures.

Research Excerpts

ExcerptRelevanceReference
"To describe the use of topical difluprednate for the treatment of uveitic macular edema."7.83Topical difluprednate monotherapy for uveitic macular edema. ( Forooghian, F; Symes, RJ, 2016)
"To describe the use of topical difluprednate for the treatment of uveitic macular edema."3.83Topical difluprednate monotherapy for uveitic macular edema. ( Forooghian, F; Symes, RJ, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Shifera, AS1
Symes, RJ1
Forooghian, F1

Other Studies

2 other studies available for fluprednisolone and Uveitis, Intermediate

ArticleYear
Bilateral Anterior and Intermediate Uveitis Associated With Omeprazole.
    The Annals of pharmacotherapy, 2020, Volume: 54, Issue:4

    Topics: Adult; Female; Fluprednisolone; Gastroesophageal Reflux; Glucocorticoids; Humans; Male; Omeprazole;

2020
Topical difluprednate monotherapy for uveitic macular edema.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2016, Volume: 51, Issue:1

    Topics: Administration, Topical; Adult; Female; Fluprednisolone; Glucocorticoids; Humans; Macular Edema; Mal

2016